13F filer · CIK 1040273 ↗
Third Point
You are looking at Q2 2016. See the latest, Q2 2026 →
Reported value
$10.49B
−3.4% on the quarter before
Positions
40
19 new · 16 sold out
Top 10
65.2%
of the value
Est. gain
+$127.3M
on stocks held all quarter
Est. return
+1.7%
on those stocks since Q1 2016
Positions as of Jun 30, 2016, from Third Point's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.
Largest buys
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$428.6MNew · 0.0% → 4.1%+3,750,000 shares
- Charter Communications Inc N~$331.5MNew · 0.0% → 3.2%+1,450,000 shares
- Monsanto Co New~$206.8MNew · 0.0% → 2.0%+2,000,000 shares
- Sherwin Williams Co~$205.6MNew · 0.0% → 2.0%+700,000 shares
- Shire Plc~$174.9MNew · 0.0% → 1.7%+950,000 shares
- S&P Global Inc~$171.6MNew · 0.0% → 1.6%+1,600,000 shares
- Ametek~$124.8MNew · 0.0% → 1.2%+2,700,000 shares
- Activision Blizzard Inc~$118.9MNew · 0.0% → 1.1%+3,000,000 shares
- Union Pac Corp~$117.8MNew · 0.0% → 1.1%+1,350,000 shares
- Allergan PlcCALL~$115.5MNew · 0.0% → 1.1%+500,000 underlying
Largest sells
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amgen Inc~$449.8MSold out · 4.1% → 0.0%−3,000,000 shares
- Yum Brands Inc~$248.8MCut · 4.1% → 2.0%−3,000,000 shares
- Dow Chem Co~$248.6MCut · 11.7% → 9.5%−5,000,000 shares
- Roper Technologies Inc~$246.7MSold out · 2.3% → 0.0%−1,350,000 shares
- Time Warner Cable Inc~$245.5MSold out · 2.3% → 0.0%−1,200,000 shares
- Baxalta Inc~$242.4MSold out · 2.2% → 0.0%−6,000,000 shares
- Alphabet~$211.1MCut · 4.9% → 2.7%−300,000 shares
- Broadcom Ltd~$200.8MSold out · 1.8% → 0.0%−1,300,000 shares
- Signet Jewelers Limited~$124.0MSold out · 1.1% → 0.0%−1,000,000 shares
- Yum Brands IncCALL~$122.8MSold out · 1.1% → 0.0%−1,500,000 underlying
Holdings
As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Intl IncCOM · shares −3.6% · price +10.1% | 22.4% | $2.35B | +$214.9M | ||||||||
| Allergan PlcSHS · shares −2.0% · price −13.8% | 10.8% | $1.13B | −$181.0M | ||||||||
| Dow Chem CoCOM · shares −20% · price −2.3% | 9.5% | $994.2M | −$23.0M | ||||||||
| MetaCL A · shares New | 4.1% | $428.6M | — | ||||||||
| Danaher Corp DelCOM · shares +4.1% · price +6.5% | 3.7% | $388.9M | +$22.7M | ||||||||
| Charter Communications Inc NCL A · shares New | 3.2% | $331.5M | — | ||||||||
| Constellation Brands IncCL A · shares +13% · price +9.5% | 3.2% | $330.8M | +$25.3M | ||||||||
| Chubb LimitedCOM · shares −2.1% · price +9.7% | 2.9% | $307.2M | +$27.2M | ||||||||
| Transdigm Group IncCOM · shares +13% · price +19.7% | 2.8% | $298.2M | +$43.3M | ||||||||
| Mohawk Inds IncCOM · shares −25% · price −0.6% | 2.7% | $284.6M | −$1.7M | ||||||||
| AlphabetCAP STK CL A · shares −43% · price −7.8% | 2.7% | $281.4M | −$23.7M | ||||||||
| Anheuser Busch Inbev Sa/NvSPONSORED ADR · shares +8.6% · price +5.6% | 2.4% | $250.2M | +$12.3M | ||||||||
| Lowes Cos IncCOM · shares 0% · price +4.5% | 2.3% | $237.5M | +$10.3M | ||||||||
| Yum Brands IncCOM · shares −55% · price +1.3% | 2.0% | $207.3M | +$2.7M | ||||||||
| Sealed Air Corp NewCOM · shares −10% · price −4.2% | 2.0% | $206.9M | −$9.2M | ||||||||
| Monsanto Co NewCOM · shares New | 2.0% | $206.8M | — | ||||||||
| Sherwin Williams CoCOM · shares New | 2.0% | $205.6M | — | ||||||||
| SothebysCOM · shares 0% · price +2.5% | 1.7% | $182.5M | +$4.5M | ||||||||
| Shire PlcSPONSORED ADR · shares New | 1.7% | $174.9M | — | ||||||||
| S&P Global IncCOM · shares New | 1.6% | $171.6M | — | ||||||||
| E M C Corp MassCOM · shares −14% · price +2.0% | 1.6% | $163.0M | +$3.1M | ||||||||
| AmetekCOM · shares New | 1.2% | $124.8M | — | ||||||||
| Activision Blizzard IncCOM · shares New | 1.1% | $118.9M | — | ||||||||
| Union Pac CorpCOM · shares New | 1.1% | $117.8M | — | ||||||||
| Allergan PlcCALLSHS · shares New | 1.1% | $115.5M | — | ||||||||
| Total · 40 positions | 100% | $10.49B | +$127.3M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2016 to Q2 2016: 21 stocks held throughout, up $127.3M (+1.7%).
- Baxter Intl Inc+$214.9M+10%
- Transdigm Group Inc+$43.3M+20%
- Chubb Limited+$27.2M+10%
- Constellation Brands Inc+$25.3M+9%
- Danaher Corp Del+$22.7M+6%
- Sealed Air Corp New−$9.2M−4%
- Nomad Hldgs Ltd−$12.0M−11%
- Dow Chem Co−$23.0M−2%
- Alphabet−$23.7M−8%
- Allergan Plc−$181.0M−14%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $4.68B+125% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $2.08B−71% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $7.27B−19% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $8.99B+18% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $7.62B+16% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $6.55B−12% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $7.44B+0% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $7.43B−15% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $8.74B+11% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $7.85B+18% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $6.64B+1% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $6.59B−3% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $6.82B+12% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.11B+2% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.97B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.53B+31% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $4.22B−45% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $7.68B−46% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $14.33B−22% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $18.32B+7% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $17.08B+15% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $14.84B+14% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $12.97B+30% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $10.00B+37% | SEC ↗ |
| Q2 2020 | Aug 17, 2020 | $7.30B+17% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $6.27B−28% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $8.70B+3% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $8.42B−1% | SEC ↗ |
| Q2 2019 | Aug 12, 2019 | $8.54B−5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $8.99B+38% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $6.51B−55% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $14.31B−0% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $14.35B+8% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $13.32B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $13.86B+16% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $11.90B+5% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $11.28B+10% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $10.25B+1% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $10.19B−11% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $11.50B+10% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $10.49B−3% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $10.86B | SEC ↗ |